These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19099191)

  • 1. The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel.
    Li QQ; Cao XX; Xu JD; Chen Q; Wang WJ; Tang F; Chen ZQ; Liu XP; Xu ZD
    Cell Mol Life Sci; 2009 Feb; 66(3):504-15. PubMed ID: 19099191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers.
    Zhang Y; Qu X; Teng Y; Li Z; Xu L; Liu J; Ma Y; Fan Y; Li C; Liu S; Wang Z; Hu X; Zhang J; Liu Y
    Oncotarget; 2015 Mar; 6(9):6737-48. PubMed ID: 25788263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rack1 mediates Src binding to drug transporter P-glycoprotein and modulates its activity through regulating Caveolin-1 phosphorylation in breast cancer cells.
    Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
    Cell Death Dis; 2019 May; 10(6):394. PubMed ID: 31113938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells.
    Xu L; Lei J; Jiang D; Zhou L; Wang S; Fan W
    Cancer Biol Ther; 2015; 16(12):1794-801. PubMed ID: 26529585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells.
    Pellegrini E; Multari G; Gallo FR; Vecchiotti D; Zazzeroni F; Condello M; Meschini S
    Toxicol Appl Pharmacol; 2022 Jan; 434():115816. PubMed ID: 34856211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
    Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
    Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTRF/cavin-1 is essential for multidrug resistance in cancer cells.
    Yi JS; Mun DG; Lee H; Park JS; Lee JW; Lee JS; Kim SJ; Cho BR; Lee SW; Ko YG
    J Proteome Res; 2013 Feb; 12(2):605-14. PubMed ID: 23214712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherent and acquired resistance to paclitaxel in hepatocellular carcinoma: molecular events involved.
    Meena AS; Sharma A; Kumari R; Mohammad N; Singh SV; Bhat MK
    PLoS One; 2013; 8(4):e61524. PubMed ID: 23613870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins.
    Jodoin J; Demeule M; Fenart L; Cecchelli R; Farmer S; Linton KJ; Higgins CF; Béliveau R
    J Neurochem; 2003 Nov; 87(4):1010-23. PubMed ID: 14622130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.
    Enokida H; Gotanda T; Oku S; Imazono Y; Kubo H; Hanada T; Suzuki S; Inomata K; Kishiye T; Tahara Y; Nishiyama K; Nakagawa M
    Jpn J Cancer Res; 2002 Sep; 93(9):1037-46. PubMed ID: 12359058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells.
    Xu W; Bae EJ; Lee MK
    Int J Nanomedicine; 2018; 13():7549-7563. PubMed ID: 30532538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface modification of paclitaxel-loaded liposomes using d-α-tocopheryl polyethylene glycol 1000 succinate: Enhanced cellular uptake and cytotoxicity in multidrug resistant breast cancer cells.
    Han SM; Baek JS; Kim MS; Hwang SJ; Cho CW
    Chem Phys Lipids; 2018 Jul; 213():39-47. PubMed ID: 29550143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trametenolic acid B reverses multidrug resistance in breast cancer cells through regulating the expression level of P-glycoprotein.
    Zhang Q; Wang J; He H; Liu H; Yan X; Zou K
    Phytother Res; 2014 Jul; 28(7):1037-44. PubMed ID: 25289403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31.
    Sun W; Wong ILK; Law HK; Su X; Chan TCF; Sun G; Yang X; Wang X; Chan TH; Wan S; Chow LMC
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance.
    Fujita T; Washio K; Takabatake D; Takahashi H; Yoshitomi S; Tsukuda K; Ishibe Y; Ogasawara Y; Doihara H; Shimizu N
    Int J Cancer; 2005 Nov; 117(4):670-82. PubMed ID: 15945097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance by novel curcumin analogues in paclitaxel-resistant human breast cancer cells.
    Gao L; Zhao P; Li Y; Yang D; Hu P; Li L; Cheng Y; Yao H
    Biochem Cell Biol; 2020 Aug; 98(4):484-491. PubMed ID: 31967866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative molecular determinants mediating sensitivity or resistance towards carnosic acid tumor cell responses.
    Mahmoud N; Saeed MEM; Sugimoto Y; Klinger A; Fleischer E; Efferth T
    Phytomedicine; 2020 Oct; 77():153271. PubMed ID: 32659679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells.
    Saeed MEM; Boulos JC; Elhaboub G; Rigano D; Saab A; Loizzo MR; Hassan LEA; Sugimoto Y; Piacente S; Tundis R; Yagi S; Khalid H; Efferth T
    Phytomedicine; 2019 Sep; 62():152945. PubMed ID: 31132750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.